Coherus BioSciences, Inc.’s CHRS share price has dipped by 12.59%, which has investors questioning if this is right time to ...

AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of ...

A review of 29 clinical trials showed that turmeric significantly reduced inflammation and pain in five types of arthritis: RA, OA, ankylosing spondylitis (AS), juvenile idiopathic arthritis ...

January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...

Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and polyarticular course juvenile idiopathic arthritis ... There were ...

Juvenile idiopathic arthritis is the most common chronic systemic disease associated with uveitis in childhood. Uveitis occurs in 11–22% of children with juvenile idiopathic arthritis.1 Due to the ...

Patients with JIA-associated uveitis who discontinued adalimumab had higher recurrence rates than those who continued the ...